Contract manufacturer specializing in AAV promotes seamless integration for successful late-stage process development.
One of the more exciting opportunities in medical technology is using a virus to carry genetic information in the form of DNA and RNA in the cells. One of the most commonly used viruses is ...
What if one of gene therapy's biggest obstacles isn't delivery, but the body's own cells? Discover why DNA silencing is ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...
StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models. Gene therapy can effectively treat various ...
Taysha Gene Therapies, Inc., (Nasdaq: TSHA) (Taysha), a clinical-stage biotechnology company focused on developing adeno-associated virus (AAV)-based gene therapies for rare, monogenic diseases of the ...
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to ...
Zilong Qiu, who is now the subject of an investigation in the death of a 6-year-old girl after the administration of an experimental gene therapy, attends the opening forum for the 2015 Xingyun Award ...
Cancer cells survive by hiding from the immune system's surveillance. A KAIST research team has developed a new anticancer ...
LOS ANGELES, Sept 28 (Reuters) - Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain earlier this month. She is doing what she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results